Biotechnology
The Biotechnology industry has a total of 592 stocks, with a combined market cap of $1.12 trillion and total revenue of $110.18 billion.
Market Cap
1.12T
Revenue
110.18B
Profits
-39.67B
PE Ratio
n/a
Profit Margin
-36.01%
Dividend Yield
0.04%
592 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.45B | - | 1,244,992 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.18B | - | 1,000,702 | 14.34B |
| 3 | ARGX | argenx SE | 46.37B | - | 372,102 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.29B | - | 872,487 | 3.71B |
| 5 | INSM | Insmed Incorporated | 35.06B | - | 1,809,387 | 606.42M |
| 6 | ONC | BeOne Medicines AG | 34.46B | - | 133,532 | 5.34B |
| 7 | RPRX | Royalty Pharma plc | 28.02B | - | 2,730,420 | 2.38B |
| 8 | BNTX | BioNTech SE | 21.88B | - | 786,750 | 3.37B |
| 9 | ROIV | Roivant Sciences Ltd. | 20.28B | - | 5,013,733 | 13.31M |
| 10 | RVMD | Revolution Medicines, Inc. | 19.64B | - | 1,331,711 | - |
| 11 | MRNA | Moderna, Inc. | 19.51B | - | 4,631,751 | 1.94B |
| 12 | INCY | Incyte Corporation | 19.09B | - | 1,160,054 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.77B | - | 1,081,616 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 15.03B | 2.43% | 3,077,322 | - |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.18B | - | 1,230,043 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 14.07B | - | 754,686 | 845.52M |
| 17 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.55B | - | 345,032 | 958.40M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.35B | - | 1,791,633 | 943.71M |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.51B | - | 695,901 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 11.40B | - | 1,664,733 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.67B | - | 2,315,876 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.27B | - | 963,118 | 5.37M |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 8.64B | - | 300,230 | 7.46M |
| 24 | AXSM | Axsome Therapeutics, Inc. | 8.62B | - | 617,094 | 638.50M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.55B | - | 1,451,847 | 1.09B |
| 26 | PCVX | Vaxcyte, Inc. | 8.40B | - | 1,017,836 | - |
| 27 | TECH | Bio-Techne Corporation | 8.31B | - | 1,802,225 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.29B | - | 992,147 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 8.22B | - | 2,479,315 | 88.04M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.64B | - | 1,523,429 | 1.40B |
| 31 | KRYS | Krystal Biotech, Inc. | 7.63B | - | 203,765 | 389.13M |
| 32 | IBRX | ImmunityBio, Inc. | 7.54B | 2.24% | 14,223,092 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.97B | - | 690,926 | 39.21M |
| 34 | ACLX | Arcellx, Inc. | 6.73B | - | 1,212,170 | 22.29M |
| 35 | BLTE | Belite Bio, Inc | 6.68B | - | 213,954 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.62B | - | 601,602 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.23B | - | 676,804 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.14B | - | 3,646,711 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | - | 10,851,347 | - |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.89B | - | 546,431 | 189.76M |
| 41 | SRRK | Scholar Rock Holding Corporation | 5.75B | - | 2,026,317 | - |
| 42 | CGON | CG Oncology, Inc. | 5.70B | - | 1,278,721 | 4.04M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 5.68B | - | 742,924 | 521.31M |
| 44 | COGT | Cogent Biosciences, Inc. | 5.67B | - | 1,968,328 | - |
| 45 | PTCT | PTC Therapeutics, Inc. | 5.61B | - | 483,034 | 1.73B |
| 46 | ERAS | Erasca, Inc. | 5.54B | - | 5,480,026 | - |
| 47 | CAI | Caris Life Sciences, Inc. | 5.45B | - | 1,541,639 | 812.03M |
| 48 | CELC | Celcuity Inc. | 5.44B | - | 501,394 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.43B | - | 897,518 | 7.50M |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.17B | - | 10,333,531 | 1.00B |
| 51 | IMVT | Immunovant, Inc. | 4.99B | - | 2,025,011 | - |
| 52 | TGTX | TG Therapeutics, Inc. | 4.95B | - | 1,531,631 | 616.29M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.75B | - | 1,727,877 | 3.51M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.55B | - | 879,705 | 2.04M |
| 55 | FOLD | Amicus Therapeutics, Inc. | 4.53B | - | 2,991,131 | 634.21M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.52B | - | 1,498,234 | 761.41M |
| 57 | VKTX | Viking Therapeutics, Inc. | 4.03B | - | 3,602,021 | - |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 3.98B | - | 221,927 | 268.09M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.90B | - | 1,247,931 | 7.70M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.79B | - | 725,310 | 22.50M |
| 61 | GPCR | Structure Therapeutics Inc. | 3.79B | - | 1,708,669 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.78B | - | 1,702,907 | 1.07B |
| 63 | SYRE | Spyre Therapeutics, Inc. | 3.74B | - | 438,075 | - |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.58B | - | 985,914 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.54B | - | 1,237,398 | 1.03B |
| 66 | DNLI | Denali Therapeutics Inc. | 3.27B | - | 1,625,807 | - |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.11B | - | 1,939,740 | - |
| 68 | TNGX | Tango Therapeutics, Inc. | 3.09B | - | 2,924,659 | 62.38M |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.03B | -1.19% | 170,292 | 803.79M |
| 70 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.02B | - | 616,268 | 588.99M |
| 71 | TARS | Tarsus Pharmaceuticals, Inc. | 2.98B | - | 370,831 | 451.36M |
| 72 | ALMS | Alumis Inc. | 2.97B | - | 1,412,367 | 24.05M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 2.93B | - | 1,092,242 | 376.07M |
| 74 | VERA | Vera Therapeutics, Inc. | 2.92B | - | 706,602 | - |
| 75 | RCUS | Arcus Biosciences, Inc. | 2.88B | - | 1,576,105 | 247.00M |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.88B | - | 694,228 | 218.71M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.81B | - | 1,149,782 | 490.73M |
| 78 | ORKA | Oruka Therapeutics, Inc. | 2.64B | - | 1,638,246 | - |
| 79 | KOD | Kodiak Sciences Inc. | 2.51B | - | 1,696,829 | - |
| 80 | IRON | Disc Medicine, Inc. | 2.49B | - | 570,244 | - |
| 81 | IMNM | Immunome, Inc. | 2.47B | - | 1,602,438 | 6.94M |
| 82 | BEAM | Beam Therapeutics Inc. | 2.45B | - | 1,853,980 | 139.74M |
| 83 | AAPG | Ascentage Pharma Group International | 2.44B | - | 6,548 | 82.08M |
| 84 | SRPT | Sarepta Therapeutics, Inc. | 2.44B | 4.97% | 3,157,599 | 2.20B |
| 85 | MANE | Veradermics, Incorporated | 2.40B | - | 839,650 | - |
| 86 | CLDX | Celldex Therapeutics, Inc. | 2.39B | - | 5,167,187 | 1.55M |
| 87 | ELVN | Enliven Therapeutics, Inc. | 2.32B | - | 810,858 | - |
| 88 | ZLAB | Zai Lab Limited | 2.30B | - | 707,427 | 460.16M |
| 89 | ADPT | Adaptive Biotechnologies Corporation | 2.28B | - | 1,565,439 | 276.98M |
| 90 | RLAY | Relay Therapeutics, Inc. | 2.24B | - | 8,891,909 | 15.36M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.22B | - | 1,645,190 | - |
| 92 | SNDX | Syndax Pharmaceuticals, Inc. | 2.22B | - | 2,093,743 | 172.35M |
| 93 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | - | 1,403,725 | 158.18M |
| 94 | NKTR | Nektar Therapeutics | 2.21B | - | 552,913 | 55.23M |
| 95 | RARE | Ultragenyx Pharmaceutical Inc. | 2.20B | - | 1,772,485 | 673.00M |
| 96 | ADMA | ADMA Biologics, Inc. | 2.19B | - | 6,126,506 | 510.17M |
| 97 | TYRA | Tyra Biosciences, Inc. | 2.13B | - | 1,048,229 | - |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.08B | - | 1,259,998 | 283.06M |
| 99 | AGIO | Agios Pharmaceuticals, Inc. | 2.06B | - | 1,425,474 | 54.03M |
| 100 | DFTX | Definium Therapeutics, Inc. | 2.06B | - | 1,957,745 | - |
| 101 | SLNO | Soleno Therapeutics, Inc. | 2.04B | 6.76% | 3,575,161 | 190.41M |
| 102 | GLPG | Galapagos NV | 1.95B | - | 176,234 | 1.31B |
| 103 | STOK | Stoke Therapeutics, Inc. | 1.94B | - | 564,305 | 184.42M |
| 104 | VRDN | Viridian Therapeutics, Inc. | 1.93B | - | 3,056,274 | 70.85M |
| 105 | ZYME | Zymeworks Inc. | 1.90B | - | 701,772 | 105.97M |
| 106 | MESO | Mesoblast Limited | 1.90B | - | 173,195 | 65.38M |
| 107 | PHVS | Pharvaris N.V. | 1.87B | - | 244,410 | - |
| 108 | OCUL | Ocular Therapeutix, Inc. | 1.85B | - | 4,374,013 | 51.95M |
| 109 | CAPR | Capricor Therapeutics, Inc. | 1.85B | - | 1,225,842 | 11.13M |
| 110 | SION | Sionna Therapeutics, Inc. | 1.82B | - | 527,755 | - |
| 111 | PVLA | Palvella Therapeutics, Inc. | 1.77B | - | 335,110 | - |
| 112 | GENB | Generate Biomedicines, Inc. | 1.75B | - | 460,799 | 31.89M |
| 113 | VCEL | Vericel Corporation | 1.74B | - | 1,685,769 | 276.26M |
| 114 | INVA | Innoviva, Inc. | 1.70B | - | 595,083 | 411.33M |
| 115 | ANAB | AnaptysBio, Inc. | 1.66B | - | 611,619 | 234.60M |
| 116 | RXRX | Recursion Pharmaceuticals, Inc. | 1.64B | 1.63% | 9,290,549 | 74.68M |
| 117 | RAPP | Rapport Therapeutics, Inc. | 1.61B | - | 219,496 | - |
| 118 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | - | 523,808 | 868.45M |
| 119 | NRIX | Nurix Therapeutics, Inc. | 1.60B | - | 1,167,303 | 83.98M |
| 120 | OCS | Oculis Holding AG | 1.58B | - | 109,785 | 1.51M |
| 121 | MBX | MBX Biosciences, Inc. | 1.57B | - | 601,684 | - |
| 122 | IMCR | Immunocore Holdings plc | 1.56B | - | 477,490 | 400.02M |
| 123 | NTLA | Intellia Therapeutics, Inc. | 1.55B | -1.06% | 2,750,476 | 67.67M |
| 124 | NBTX | Nanobiotix S.A. | 1.53B | - | 98,739 | 38.27M |
| 125 | TRVI | Trevi Therapeutics, Inc. | 1.53B | - | 1,218,906 | - |
| 126 | DMRA | Damora Therapeutics, Inc. | 1.51B | - | 237,873 | - |
| 127 | NUVB | Nuvation Bio Inc. | 1.51B | - | 2,413,695 | 62.90M |
| 128 | BHVN | Biohaven Ltd. | 1.47B | - | 2,600,206 | - |
| 129 | ARDX | Ardelyx, Inc. | 1.46B | - | 2,400,587 | 407.32M |
| 130 | VIR | Vir Biotechnology, Inc. | 1.45B | - | 1,727,274 | 68.56M |
| 131 | MAZE | Maze Therapeutics, Inc. | 1.43B | - | 780,450 | 2.50M |
| 132 | IOVA | Iovance Biotherapeutics, Inc. | 1.41B | - | 7,803,480 | 263.50M |
| 133 | SVRA | Savara Inc. | 1.41B | - | 811,621 | - |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.41B | - | 919,828 | - |
| 135 | PGEN | Precigen, Inc. | 1.39B | - | 5,457,994 | 9.68M |
| 136 | IMTX | Immatics N.V. | 1.39B | - | 440,054 | 56.67M |
| 137 | ATAI | AtaiBeckley Inc. | 1.38B | - | 3,055,073 | 4.09M |
| 138 | WVE | Wave Life Sciences Ltd. | 1.37B | - | 4,068,718 | 42.73M |
| 139 | GLUE | Monte Rosa Therapeutics, Inc. | 1.37B | - | 1,240,324 | 123.67M |
| 140 | OLMA | Olema Pharmaceuticals, Inc. | 1.31B | - | 904,353 | - |
| 141 | ZBIO | Zenas BioPharma, Inc. | 1.28B | - | 1,722,639 | 10.00M |
| 142 | TSHA | Taysha Gene Therapies, Inc. | 1.26B | - | 1,581,008 | 9.77M |
| 143 | NVAX | Novavax, Inc. | 1.25B | - | 4,662,730 | 1.12B |
| 144 | MLTX | MoonLake Immunotherapeutics | 1.25B | - | 1,687,063 | - |
| 145 | CRVS | Corvus Pharmaceuticals, Inc. | 1.23B | - | 660,473 | - |
| 146 | DBVT | DBV Technologies S.A. | 1.17B | - | 446,576 | 5.64M |
| 147 | PHAR | Pharming Group N.V. | 1.16B | - | 41,591 | 376.13M |
| 148 | SEPN | Septerna, Inc. | 1.13B | - | 288,093 | 45.95M |
| 149 | EYPT | EyePoint, Inc. | 1.12B | - | 1,154,744 | 31.37M |
| 150 | AVBP | ArriVent BioPharma, Inc. | 1.10B | - | 362,944 | - |
| 151 | QURE | uniQure N.V. | 1.07B | - | 1,193,029 | 16.10M |
| 152 | ABCL | AbCellera Biologics Inc. | 1.07B | - | 3,490,358 | 75.13M |
| 153 | GERN | Geron Corporation | 1.06B | - | 33,581,583 | 183.88M |
| 154 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | - | 1,338,753 | 291.85M |
| 155 | IVA | Inventiva S.A. | 1.04B | - | 321,489 | 9.31M |
| 156 | KALV | KalVista Pharmaceuticals, Inc. | 1.02B | - | 910,772 | 73.62M |
| 157 | CTMX | CytomX Therapeutics, Inc. | 985.77M | - | 4,718,182 | 76.20M |
| 158 | CMPX | Compass Therapeutics, Inc. | 981.48M | - | 3,183,387 | 850.00K |
| 159 | VOR | Vor Biopharma Inc. | 978.05M | - | 1,525,854 | - |
| 160 | AKTS | Aktis Oncology, Inc. | 960.14M | - | 380,427 | 6.50M |
| 161 | XNCR | Xencor, Inc. | 939.47M | - | 608,555 | 125.58M |
| 162 | MPLT | MapLight Therapeutics, Inc. | 931.99M | - | 146,588 | - |
| 163 | INBX | Inhibrx Biosciences, Inc. | 927.98M | - | 190,000 | 1.30M |
| 164 | URGN | UroGen Pharma Ltd. | 916.20M | - | 382,344 | 109.79M |
| 165 | GHRS | GH Research PLC | 903.77M | - | 102,677 | - |
| 166 | JANX | Janux Therapeutics, Inc. | 902.74M | - | 1,305,021 | 10.00M |
| 167 | PHAT | Phathom Pharmaceuticals, Inc. | 893.58M | - | 786,348 | 175.11M |
| 168 | ORIC | ORIC Pharmaceuticals, Inc. | 892.18M | 18.85% | 7,289,337 | - |
| 169 | FTRE | Fortrea Holdings Inc. | 883.58M | - | 845,544 | 2.72B |
| 170 | ANNX | Annexon, Inc. | 882.61M | - | 3,331,285 | - |
| 171 | ABUS | Arbutus Biopharma Corporation | 875.74M | - | 612,471 | 14.08M |
| 172 | CGEM | Cullinan Therapeutics, Inc. | 873.39M | - | 1,149,608 | - |
| 173 | EVMN | Evommune, Inc. | 854.36M | - | 380,647 | 13.00M |
| 174 | SANA | Sana Biotechnology, Inc. | 853.97M | - | 3,285,581 | - |
| 175 | TBPH | Theravance Biopharma, Inc. | 824.92M | - | 508,782 | 107.46M |
| 176 | SPRY | ARS Pharmaceuticals, Inc. | 824.17M | - | 1,277,290 | 84.28M |
| 177 | OMER | Omeros Corporation | 784.76M | - | 1,837,300 | - |
| 178 | MNKD | MannKind Corporation | 770.25M | - | 3,758,383 | 348.97M |
| 179 | JBIO | Jade Biosciences, Inc. | 763.91M | - | 403,279 | - |
| 180 | KURA | Kura Oncology, Inc. | 760.52M | - | 4,391,977 | 67.48M |
| 181 | MRVI | Maravai LifeSciences Holdings, Inc. | 758.35M | - | 1,751,631 | 185.74M |
| 182 | TENX | Tenax Therapeutics, Inc. | 755.26M | - | 335,121 | - |
| 183 | SGP | SpyGlass Pharma, Inc. | 750.76M | - | 137,963 | - |
| 184 | MGTX | MeiraGTx Holdings plc | 747.68M | - | 1,094,807 | 81.39M |
| 185 | SLS | SELLAS Life Sciences Group, Inc. | 741.68M | - | 4,872,646 | - |
| 186 | SLDB | Solid Biosciences Inc. | 736.95M | - | 808,779 | - |
| 187 | RLMD | Relmada Therapeutics, Inc. | 733.18M | - | 1,846,131 | - |
| 188 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 713.09M | - | 164,855 | - |
| 189 | REPL | Replimune Group, Inc. | 694.44M | 10.51% | 3,185,142 | - |
| 190 | ARVN | Arvinas, Inc. | 693.98M | - | 1,289,359 | 262.60M |
| 191 | DSGN | Design Therapeutics, Inc. | 692.58M | - | 314,296 | - |
| 192 | ANRO | Alto Neuroscience, Inc. | 692.58M | - | 710,509 | - |
| 193 | DRUG | Bright Minds Biosciences Inc. | 689.00M | - | 188,468 | - |
| 194 | LXRX | Lexicon Pharmaceuticals, Inc. | 673.65M | - | 2,316,350 | 49.80M |
| 195 | GYRE | Gyre Therapeutics, Inc. | 650.16M | - | 63,540 | 116.59M |
| 196 | LBRX | LB Pharmaceuticals Inc | 649.93M | - | 342,090 | - |
| 197 | CBIO | Crescent Biopharma, Inc. | 644.35M | - | 209,010 | 10.84M |
| 198 | DRTS | Alpha Tau Medical Ltd. | 609.03M | - | 168,396 | - |
| 199 | OCGN | Ocugen, Inc. | 604.84M | - | 5,037,360 | 4.41M |
| 200 | ALLO | Allogene Therapeutics, Inc. | 604.57M | - | 4,331,502 | 22.00K |
| 201 | PRME | Prime Medicine, Inc. | 587.90M | - | 1,651,407 | 4.63M |
| 202 | ACRS | Aclaris Therapeutics, Inc. | 583.78M | - | 940,068 | 7.83M |
| 203 | MDXG | MiMedx Group, Inc. | 582.38M | - | 1,678,657 | 418.63M |
| 204 | PROK | ProKidney Corp. | 573.64M | - | 1,053,710 | 893.00K |
| 205 | TECX | Tectonic Therapeutic, Inc. | 573.06M | - | 163,056 | - |
| 206 | ZURA | Zura Bio Limited | 572.13M | - | 444,928 | - |
| 207 | CRMD | CorMedix Inc. | 557.31M | - | 1,671,219 | 311.71M |
| 208 | ZVRA | Zevra Therapeutics, Inc. | 551.89M | - | 587,490 | 106.47M |
| 209 | VALN | Valneva SE | 543.61M | - | 248,390 | 205.07M |
| 210 | KYTX | Kyverna Therapeutics, Inc. | 536.24M | - | 757,061 | - |
| 211 | EIKN | Eikon Therapeutics, Inc. | 535.97M | - | 252,605 | - |
| 212 | FULC | Fulcrum Therapeutics, Inc. | 535.47M | - | 1,012,333 | 80.00M |
| 213 | PRTA | Prothena Corporation plc | 530.79M | - | 849,122 | 9.68M |
| 214 | YDES | YD Bio Limited | 522.48M | - | 8,824 | 510.36K |
| 215 | AGMB | AgomAb Therapeutics NV | 522.46M | - | 185,548 | - |
| 216 | UPB | Upstream Bio, Inc. | 516.99M | - | 537,603 | 2.85M |
| 217 | VTVT | vTv Therapeutics Inc. | 510.90M | - | 40,993 | 17.00K |
| 218 | RIGL | Rigel Pharmaceuticals, Inc. | 508.57M | - | 186,532 | 294.28M |
| 219 | CTNM | Contineum Therapeutics, Inc. | 501.80M | - | 111,074 | - |
| 220 | LRMR | Larimar Therapeutics, Inc. | 497.60M | - | 994,381 | - |
| 221 | VSTM | Verastem, Inc. | 494.51M | - | 1,837,872 | 30.91M |
| 222 | LYEL | Lyell Immunopharma, Inc. | 494.34M | - | 88,861 | 36.00K |
| 223 | FDMT | 4D Molecular Therapeutics, Inc. | 483.97M | - | 706,932 | 85.21M |
| 224 | ADCT | ADC Therapeutics SA | 480.23M | - | 1,355,063 | 81.36M |
| 225 | FBRX | Forte Biosciences, Inc. | 480.09M | - | 241,649 | - |
| 226 | IMMX | Immix Biopharma, Inc. | 473.50M | - | 418,142 | - |
| 227 | TRDA | Entrada Therapeutics, Inc. | 473.40M | - | 178,008 | 25.42M |
| 228 | ABSI | Absci Corporation | 468.25M | - | 4,676,279 | 2.80M |
| 229 | ASMB | Assembly Biosciences, Inc. | 460.18M | - | 37,857 | 72.30M |
| 230 | STTK | Shattuck Labs, Inc. | 459.44M | - | 443,022 | 1.00M |
| 231 | AVIR | Atea Pharmaceuticals, Inc. | 458.91M | - | 442,901 | - |
| 232 | ENGN | enGene Holdings Inc. | 448.16M | - | 332,808 | - |
| 233 | RGNX | REGENXBIO Inc. | 440.26M | - | 420,975 | 170.44M |
| 234 | EPRX | Eupraxia Pharmaceuticals Inc. | 439.78M | - | 259,638 | - |
| 235 | ALT | Altimmune, Inc. | 434.55M | 7.05% | 2,737,035 | 41.00K |
| 236 | LXEO | Lexeo Therapeutics, Inc. | 423.78M | - | 625,751 | - |
| 237 | AURA | Aura Biosciences, Inc. | 419.54M | - | 175,767 | - |
| 238 | NAUT | Nautilus Biotechnology, Inc. | 418.30M | -1.49% | 218,141 | - |
| 239 | VNDA | Vanda Pharmaceuticals Inc. | 413.76M | - | 920,012 | 216.11M |
| 240 | AVTX | Avalo Therapeutics, Inc. | 404.72M | - | 1,109,152 | 59.00K |
| 241 | DNA | Ginkgo Bioworks Holdings, Inc. | 401.63M | - | 1,438,261 | 170.16M |
| 242 | STRO | Sutro Biopharma, Inc. | 393.97M | - | 126,595 | 102.48M |
| 243 | XOMA | XOMA Royalty Corporation | 392.98M | - | 93,568 | 52.15M |
| 244 | LCTX | Lineage Cell Therapeutics, Inc. | 391.07M | - | 581,885 | 14.56M |
| 245 | XFOR | X4 Pharmaceuticals, Inc. | 385.50M | - | 206,100 | 35.11M |
| 246 | RCKT | Rocket Pharmaceuticals, Inc. | 385.42M | - | 2,286,672 | - |
| 247 | IPSC | Century Therapeutics, Inc. | 382.81M | - | 678,760 | 109.16M |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 381.31M | - | 112,824 | 66.98M |
| 249 | AUTL | Autolus Therapeutics plc | 375.26M | - | 1,033,400 | 75.39M |
| 250 | BNTC | Benitec Biopharma Inc. | 374.06M | - | 53,609 | - |
| 251 | ARMP | Armata Pharmaceuticals, Inc. | 372.92M | - | 22,948 | 4.90M |
| 252 | MNPR | Monopar Therapeutics Inc. | 368.41M | - | 145,147 | - |
| 253 | CADL | Candel Therapeutics, Inc. | 366.23M | - | 910,354 | - |
| 254 | PRTC | PureTech Health plc | 364.17M | - | 12,350 | 6.39M |
| 255 | NMRA | Neumora Therapeutics, Inc. | 364.08M | - | 1,238,189 | - |
| 256 | IVVD | Invivyd, Inc. | 361.72M | -3.76% | 3,902,681 | 53.43M |
| 257 | IMRX | Immuneering Corporation | 352.36M | - | 597,449 | - |
| 258 | BCYC | Bicycle Therapeutics plc | 352.02M | - | 325,064 | 72.59M |
| 259 | NAGE | Niagen Bioscience, Inc. | 351.48M | - | 752,868 | 129.42M |
| 260 | PBYI | Puma Biotechnology, Inc. | 351.05M | - | 347,512 | 228.37M |
| 261 | DMAC | DiaMedica Therapeutics Inc. | 349.16M | - | 131,417 | - |
| 262 | NGEN | NervGen Pharma Corp. | 343.49M | - | 611,817 | - |
| 263 | PLYX | Polaryx Therapeutics, Inc. | 338.03M | - | 251,901 | - |
| 264 | CABA | Cabaletta Bio, Inc. | 329.52M | 10.45% | 2,106,813 | - |
| 265 | RZLT | Rezolute, Inc. | 324.08M | - | 686,175 | - |
| 266 | IRD | Opus Genetics, Inc. | 323.73M | - | 348,147 | 14.20M |
| 267 | NGNE | Neurogene Inc. | 322.23M | - | 182,557 | 925.00K |
| 268 | SRZN | Surrozen, Inc. | 320.13M | - | 35,912 | 3.48M |
| 269 | PALI | Palisade Bio, Inc. | 316.43M | 0.53% | 2,540,218 | - |
| 270 | GLSI | Greenwich LifeSciences, Inc. | 316.16M | - | 54,545 | - |
| 271 | CLYM | Climb Bio, Inc. | 313.36M | - | 441,296 | - |
| 272 | IKT | Inhibikase Therapeutics, Inc. | 306.76M | - | 759,860 | 1.00 |
| 273 | LENZ | LENZ Therapeutics, Inc. | 303.20M | - | 698,271 | 19.09M |
| 274 | ANL | Adlai Nortye Ltd. | 301.84M | - | 454,611 | -1.35M |
| 275 | OVID | Ovid Therapeutics Inc. | 290.12M | - | 1,402,235 | 7.25M |
| 276 | FHTX | Foghorn Therapeutics Inc. | 289.39M | - | 87,679 | 30.91M |
| 277 | PRLD | Prelude Therapeutics Incorporated | 285.57M | - | 105,678 | 12.14M |
| 278 | SLN | Silence Therapeutics plc | 280.57M | - | 285,704 | 559.00K |
| 279 | NBP | NovaBridge Biosciences | 280.16M | - | 1,524,552 | - |
| 280 | AVXL | Anavex Life Sciences Corp. | 277.09M | - | 1,166,347 | - |
| 281 | TARA | Protara Therapeutics, Inc. | 276.37M | - | 511,530 | - |
| 282 | CCCC | C4 Therapeutics, Inc. | 275.17M | - | 2,127,268 | 35.95M |
| 283 | ABEO | Abeona Therapeutics Inc. | 274.98M | - | 766,632 | 5.82M |
| 284 | ACIU | AC Immune SA | 273.80M | - | 119,826 | 4.51M |
| 285 | SABS | SAB Biotherapeutics, Inc. | 272.67M | - | 205,340 | 114.70K |
| 286 | ALEC | Alector, Inc. | 265.97M | - | 1,316,858 | 21.05M |
| 287 | ADAG | Adagene Inc. | 263.63M | - | 1,225,671 | 7.67M |
| 288 | EDIT | Editas Medicine, Inc. | 261.32M | - | 1,125,211 | 40.52M |
| 289 | CLLS | Cellectis S.A. | 260.21M | - | 28,663 | 79.59M |
| 290 | SLGL | Sol-Gel Technologies Ltd. | 259.75M | - | 80,100 | 19.39M |
| 291 | CHRS | Coherus Oncology, Inc. | 259.31M | - | 537,249 | 42.17M |
| 292 | ALXO | ALX Oncology Holdings Inc. | 259.27M | - | 415,130 | - |
| 293 | HELP | Cybin Inc. | 256.18M | 2.61% | 895,334 | - |
| 294 | CNTX | Context Therapeutics Inc. | 249.91M | - | 1,100,116 | - |
| 295 | OBIO | Orchestra BioMed Holdings, Inc. | 249.88M | - | 139,841 | 33.48M |
| 296 | KROS | Keros Therapeutics, Inc. | 236.61M | - | 559,050 | 244.06M |
| 297 | VYGR | Voyager Therapeutics, Inc. | 236.01M | - | 462,535 | 40.37M |
| 298 | ELDN | Eledon Pharmaceuticals, Inc. | 233.22M | - | 1,187,846 | - |
| 299 | CAMP | Camp4 Therapeutics Corporation | 232.08M | - | 38,013 | 3.50M |
| 300 | NERV | Minerva Neurosciences, Inc. | 228.49M | - | 188,601 | - |
| 301 | ARCT | Arcturus Therapeutics Holdings Inc. | 228.24M | - | 506,121 | 82.03M |
| 302 | ENLV | Enlivex Ltd. | 225.99M | - | 307,478 | - |
| 303 | OABI | OmniAb, Inc. | 222.97M | - | 273,622 | 18.67M |
| 304 | FENC | Fennec Pharmaceuticals Inc. | 221.33M | - | 267,076 | 44.64M |
| 305 | MDWD | MediWound Ltd. | 216.05M | - | 299,657 | 16.96M |
| 306 | CGEN | Compugen Ltd. | 213.69M | - | 205,711 | 72.76M |
| 307 | KRRO | Korro Bio, Inc. | 201.92M | - | 303,717 | 6.39M |
| 308 | NVCT | Nuvectis Pharma, Inc. | 200.28M | - | 18,276 | - |
| 309 | TNXP | Tonix Pharmaceuticals Holding Corp. | 197.46M | - | 313,871 | 13.11M |
| 310 | ELTX | Elicio Therapeutics, Inc. | 195.92M | - | 69,298 | - |
| 311 | MGNX | MacroGenics, Inc. | 195.12M | - | 713,840 | 149.50M |
| 312 | ABOS | Acumen Pharmaceuticals, Inc. | 194.97M | - | 635,910 | - |
| 313 | MENS | Jyong Biotech Ltd. | 188.41M | - | 174,728 | - |
| 314 | CRBU | Caribou Biosciences, Inc. | 187.48M | - | 1,063,880 | 11.16M |
| 315 | ZNTL | Zentalis Pharmaceuticals, Inc. | 186.55M | - | 358,117 | 26.87M |
| 316 | CNTN | Canton Strategic Holdings, Inc. | 184.70M | - | 394,808 | - |
| 317 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 180.38M | - | 236,352 | - |
| 318 | PRQR | ProQR Therapeutics N.V. | 180.17M | - | 241,182 | 19.19M |
| 319 | GALT | Galectin Therapeutics Inc. | 175.76M | - | 242,842 | - |
| 320 | UNCY | Unicycive Therapeutics, Inc. | 174.90M | - | 491,262 | - |
| 321 | SGMT | Sagimet Biosciences Inc. | 173.35M | - | 160,019 | - |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 173.23M | - | 1,100,329 | 52.74M |
| 323 | ACHV | Achieve Life Sciences, Inc. | 171.97M | - | 504,864 | - |
| 324 | MIST | Milestone Pharmaceuticals Inc. | 169.26M | - | 2,088,242 | 1.55M |
| 325 | CNTB | Connect Biopharma Holdings Limited | 169.00M | - | 859,168 | 64.00K |
| 326 | ARTV | Artiva Biotherapeutics, Inc. | 166.59M | - | 146,296 | 251.00K |
| 327 | RNAC | Cartesian Therapeutics, Inc. | 165.95M | - | 60,433 | 2.80M |
| 328 | WHWK | Whitehawk Therapeutics, Inc. | 165.66M | - | 94,903 | 7.15M |
| 329 | NKTX | Nkarta, Inc. | 165.39M | - | 449,819 | - |
| 330 | CDXS | Codexis, Inc. | 165.38M | - | 786,380 | 70.39M |
| 331 | TLSA | Tiziana Life Sciences Ltd | 159.53M | - | 111,134 | - |
| 332 | IMUX | Immunic, Inc. | 151.34M | - | 808,628 | - |
| 333 | MOLN | Molecular Partners AG | 151.17M | - | 3,272 | 856.30K |
| 334 | CBUS | Cibus, Inc. | 150.82M | - | 375,010 | 3.64M |
| 335 | TNYA | Tenaya Therapeutics, Inc. | 150.73M | - | 1,507,035 | - |
| 336 | HRTX | Heron Therapeutics, Inc. | 150.68M | - | 913,792 | 154.90M |
| 337 | DTIL | Precision BioSciences, Inc. | 150.17M | - | 303,810 | 34.26M |
| 338 | HUMA | Humacyte, Inc. | 142.63M | 8.53% | 4,820,077 | 2.04M |
| 339 | FATE | Fate Therapeutics, Inc. | 141.84M | - | 660,548 | 6.65M |
| 340 | NTHI | NeOnc Technologies Holdings, Inc. | 141.65M | - | 99,559 | 39.99K |
| 341 | SPRO | Spero Therapeutics, Inc. | 140.68M | - | 214,375 | 66.80M |
| 342 | ORMP | Oramed Pharmaceuticals Inc. | 138.33M | - | 42,942 | 2.00M |
| 343 | BDTX | Black Diamond Therapeutics, Inc. | 136.92M | - | 535,680 | 70.00M |
| 344 | KPTI | Karyopharm Therapeutics Inc. | 132.78M | - | 185,498 | 146.07M |
| 345 | KLRS | Kalaris Therapeutics, Inc. | 132.75M | - | 23,573 | - |
| 346 | ACOG | Alpha Cognition Inc. | 130.02M | - | 56,401 | 10.22M |
| 347 | AGEN | Agenus Inc. | 127.87M | - | 480,752 | 114.20M |
| 348 | IPHA | Innate Pharma S.A. | 125.73M | - | 17,252 | 10.57M |
| 349 | EQ | Equillium, Inc. | 124.56M | - | 135,433 | 4.39M |
| 350 | SGMO | Sangamo Therapeutics, Inc. | 124.32M | - | 8,775,508 | 39.55M |
| 351 | PEPG | PepGen Inc. | 119.57M | - | 1,716,761 | - |
| 352 | ANTX | AN2 Therapeutics, Inc. | 117.53M | - | 412,080 | - |
| 353 | GNLX | Genelux Corporation | 114.04M | - | 138,318 | 8.00K |
| 354 | PMN | ProMIS Neurosciences, Inc. | 112.19M | - | 32,517 | - |
| 355 | ONCY | Oncolytics Biotech Inc. | 111.52M | - | 640,402 | - |
| 356 | BMEA | Biomea Fusion, Inc. | 111.34M | - | 1,183,563 | - |
| 357 | CRDF | Cardiff Oncology, Inc. | 108.02M | - | 528,628 | 593.00K |
| 358 | LONA | LeonaBio, Inc. | 106.62M | - | 56,494 | - |
| 359 | ALDX | Aldeyra Therapeutics, Inc. | 99.90M | -1.19% | 1,820,469 | - |
| 360 | TTRX | Turn Therapeutics Inc. | 98.64M | - | 39,116 | - |
| 361 | SPRB | Spruce Biosciences, Inc. | 96.72M | - | 37,546 | 697.00K |
| 362 | SEER | Seer, Inc. | 95.92M | - | 61,819 | 16.58M |
| 363 | COYA | Coya Therapeutics, Inc. | 94.06M | - | 76,017 | 7.95M |
| 364 | VRCA | Verrica Pharmaceuticals Inc. | 93.97M | - | 38,647 | 35.58M |
| 365 | AARD | Aardvark Therapeutics, Inc. | 93.81M | - | 134,748 | - |
| 366 | INO | Inovio Pharmaceuticals, Inc. | 93.69M | -35.06% | 19,933,832 | 65.34K |
| 367 | QTTB | Q32 Bio Inc. | 93.34M | - | 166,635 | 53.74M |
| 368 | PYXS | Pyxis Oncology, Inc. | 92.99M | - | 195,846 | 13.86M |
| 369 | VANI | Vivani Medical, Inc. | 91.42M | - | 147,818 | - |
| 370 | HURA | TuHURA Biosciences, Inc. | 89.65M | - | 1,213,239 | - |
| 371 | MCRB | Seres Therapeutics, Inc. | 88.86M | - | 76,889 | 789.00K |
| 372 | OKYO | OKYO Pharma Limited | 88.17M | - | 71,830 | - |
| 373 | GOSS | Gossamer Bio, Inc. | 86.84M | - | 5,810,717 | 48.47M |
| 374 | ANIX | Anixa Biosciences, Inc. | 85.50M | - | 70,023 | - |
| 375 | KZIA | Kazia Therapeutics Limited | 83.87M | - | 28,532 | 1.27M |
| 376 | PYPD | PolyPid Ltd. | 83.78M | - | 54,259 | - |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 83.75M | - | 1,062,884 | 1.63M |
| 378 | PLRX | Pliant Therapeutics, Inc. | 83.58M | - | 521,602 | - |
| 379 | FLNA | Filana Therapeutics, Inc. | 83.57M | - | 302,730 | - |
| 380 | ATYR | aTyr Pharma, Inc. | 83.04M | - | 704,056 | 190.00K |
| 381 | NRXS | NeurAxis, Inc. | 81.11M | - | 44,032 | 3.57M |
| 382 | FBIO | Fortress Biotech, Inc. | 80.70M | - | 522,463 | 63.26M |
| 383 | MAIA | MAIA Biotechnology, Inc. | 80.69M | - | 271,311 | - |
| 384 | CSBR | Champions Oncology, Inc. | 80.13M | - | 2,911 | 57.95M |
| 385 | GRCE | Grace Therapeutics, Inc. | 79.38M | - | 670,445 | - |
| 386 | GANX | Gain Therapeutics, Inc. | 78.15M | - | 522,941 | - |
| 387 | CGTX | Cognition Therapeutics, Inc. | 77.56M | - | 1,048,987 | - |
| 388 | ACET | Adicet Bio, Inc. | 75.14M | - | 64,016 | - |
| 389 | COEP | Coeptis Therapeutics Holdings, Inc. | 74.55M | - | 17,405 | 1.36M |
| 390 | EXOZ | eXoZymes, Inc. | 74.11M | - | 3,660 | -700.00 |
| 391 | NRXP | NRx Pharmaceuticals, Inc. | 72.68M | - | 355,907 | 1.23M |
| 392 | GUTS | Fractyl Health, Inc. | 72.33M | - | 1,504,528 | 3.00K |
| 393 | XBIT | XBiotech Inc. | 71.65M | - | 6,419 | - |
| 394 | PMVP | PMV Pharmaceuticals, Inc. | 71.46M | - | 100,098 | - |
| 395 | CING | Cingulate Inc. | 71.40M | - | 330,335 | - |
| 396 | BYSI | BeyondSpring Inc. | 70.93M | - | 2,351 | 1.88M |
| 397 | MNOV | MediciNova, Inc. | 70.88M | - | 36,672 | 409.66K |
| 398 | DWTX | Dogwood Therapeutics, Inc. | 70.48M | - | 18,856 | - |
| 399 | PTHS | Pelthos Therapeutics Inc. | 68.45M | - | 10,038 | 16.80M |
| 400 | IBIO | iBio, Inc. | 68.40M | - | 321,089 | 300.00K |
| 401 | ATHE | Alterity Therapeutics Limited | 67.60M | 0.01% | 2,896 | 4.43M |
| 402 | IFRX | InflaRx N.V. | 65.96M | - | 265,365 | 34.44K |
| 403 | ANVS | Annovis Bio, Inc. | 64.65M | 7.55% | 962,628 | - |
| 404 | IBO | Impact BioMedical Inc. | 63.68M | - | 44,063 | 32.00K |
| 405 | ACRV | Acrivon Therapeutics, Inc. | 58.89M | - | 393,322 | - |
| 406 | ACTU | Actuate Therapeutics, Inc. | 58.80M | - | 42,825 | - |
| 407 | ENTX | Entera Bio Ltd. | 58.74M | - | 742,504 | 42.00K |
| 408 | OKUR | OnKure Therapeutics, Inc. | 58.66M | - | 342,020 | - |
| 409 | ICCC | ImmuCell Corporation | 58.26M | - | 6,897 | 27.64M |
| 410 | TCRX | TScan Therapeutics, Inc. | 57.47M | - | 672,909 | 10.33M |
| 411 | HYFT | MindWalk Holdings Corp. | 56.62M | - | 154,975 | 20.70M |
| 412 | IMA | ImageneBio, Inc. | 55.59M | - | 14,549 | 800.00K |
| 413 | KZR | Kezar Life Sciences, Inc. | 54.55M | - | 53,420 | - |
| 414 | TIL | Instil Bio, Inc. | 54.46M | - | 23,783 | - |
| 415 | OSTX | OS Therapies Incorporated | 53.77M | - | 188,726 | - |
| 416 | NBY | NovaBay Pharmaceuticals, Inc. | 51.92M | - | 637,597 | 10.30M |
| 417 | RADX | Radiopharm Theranostics Limited | 51.41M | - | 24,167 | 10.86M |
| 418 | EDSA | Edesa Biotech, Inc. | 51.26M | - | 418,062 | - |
| 419 | MREO | Mereo BioPharma Group plc | 51.08M | - | 2,321,172 | 500.00K |
| 420 | MGX | Metagenomi Therapeutics, Inc. | 50.79M | - | 83,135 | 25.21M |
| 421 | INKT | MiNK Therapeutics, Inc. | 50.18M | - | 35,869 | - |
| 422 | ALGS | Aligos Therapeutics, Inc. | 49.32M | - | 39,566 | 2.19M |
| 423 | XLO | Xilio Therapeutics, Inc. | 49.21M | - | 25,998 | 43.77M |
| 424 | HOWL | Werewolf Therapeutics, Inc. | 49.08M | - | 402,894 | 1.14M |
| 425 | ATOS | Atossa Therapeutics, Inc. | 46.20M | - | 71,797 | - |
| 426 | LSTA | Lisata Therapeutics, Inc. | 45.34M | - | 15,337 | 170.00K |
| 427 | ESLA | Estrella Immunopharma, Inc. | 44.80M | - | 10,385 | - |
| 428 | IMMP | Immutep Limited | 44.79M | - | 284,416 | 5.28M |
| 429 | RLYB | Rallybio Corporation | 44.59M | - | 14,564 | 858.00K |
| 430 | RNXT | RenovoRx, Inc. | 44.15M | - | 130,087 | 1.12M |
| 431 | NTRB | Nutriband Inc. | 44.13M | - | 9,797 | 2.28M |
| 432 | TELO | Telomir Pharmaceuticals, Inc. | 43.66M | - | 87,415 | - |
| 433 | ATRA | Atara Biotherapeutics, Inc. | 40.81M | - | 47,023 | 120.77M |
| 434 | LITS | Lite Strategy, Inc. | 40.73M | - | 218,871 | - |
| 435 | SNSE | Sensei Biotherapeutics, Inc. | 39.25M | - | 66,426 | - |
| 436 | CELU | Celularity Inc. | 38.35M | - | 12,939 | 40.58M |
| 437 | CRVO | CervoMed Inc. | 38.33M | - | 72,250 | 4.01M |
| 438 | NXTC | NextCure, Inc. | 38.17M | - | 10,785 | - |
| 439 | HYPD | Hyperion DeFi, Inc. | 37.02M | - | 454,658 | 813.46K |
| 440 | VERU | Veru Inc. | 36.76M | - | 32,409 | 16.89M |
| 441 | PDSB | PDS Biotechnology Corporation | 34.75M | - | 234,111 | - |
| 442 | RNTX | Rein Therapeutics Inc. | 33.93M | - | 155,082 | - |
| 443 | PTN | Palatin Technologies, Inc. | 33.64M | - | 16,527 | 8.96M |
| 444 | PLUR | Pluri Inc. | 33.37M | - | 4,515 | 1.34M |
| 445 | DYAI | Dyadic International, Inc. | 32.43M | - | 33,296 | 3.09M |
| 446 | INMB | INmune Bio Inc. | 32.17M | - | 323,322 | 50.00K |
| 447 | APLM | Apollomics, Inc. | 31.61M | - | - | 6.93M |
| 448 | EVAX | Evaxion A/S | 31.53M | - | 3,802 | 7.53M |
| 449 | LGVN | Longeveron Inc. | 31.33M | - | 1,195,325 | 1.20M |
| 450 | ATNM | Actinium Pharmaceuticals, Inc. | 30.56M | - | 59,350 | 90.00K |
| 451 | BCTX | BriaCell Therapeutics Corp. | 29.39M | - | 112,131 | - |
| 452 | NRSN | NeuroSense Therapeutics Ltd. | 29.34M | - | 99,044 | - |
| 453 | KYNB | Kyntra Bio, Inc. | 28.37M | - | 11,550 | 6.44M |
| 454 | TVRD | Tvardi Therapeutics, Inc. | 28.33M | - | 63,367 | - |
| 455 | CVM | CEL-SCI Corporation | 28.08M | - | 18,144 | - |
| 456 | ABVC | ABVC BioPharma, Inc. | 26.93M | - | 54,760 | 797.92K |
| 457 | XCUR | Exicure, Inc. | 26.71M | - | 8,450 | 500.00K |
| 458 | SNTI | Senti Biosciences, Inc. | 26.67M | - | 86,056 | 22.00K |
| 459 | LIXT | Lixte Biotechnology Holdings, Inc. | 26.57M | - | 21,816 | - |
| 460 | SER | Serina Therapeutics, Inc. | 26.11M | - | 409,588 | 130.00K |
| 461 | CYCN | Cyclerion Therapeutics, Inc. | 25.99M | - | 11,363,119 | 2.07M |
| 462 | PASG | Passage Bio, Inc. | 25.92M | - | 18,279 | - |
| 463 | LEXX | Lexaria Bioscience Corp. | 25.88M | - | 668,358 | 522.00K |
| 464 | IGC | IGC Pharma, Inc. | 25.40M | - | 91,487 | 1.11M |
| 465 | DARE | Daré Bioscience, Inc. | 25.33M | - | 94,404 | 1.03M |
| 466 | BRNS | Barinthus Biotherapeutics plc | 24.51M | - | 19,134 | 14.97M |
| 467 | PSTV | Plus Therapeutics, Inc. | 24.43M | - | 616,618 | 5.21M |
| 468 | BOLD | Boundless Bio, Inc. | 24.20M | - | 268,574 | - |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 23.77M | - | 62,917 | 14.99M |
| 470 | QNTM | Quantum BioPharma Ltd. | 23.46M | - | 443,750 | - |
| 471 | SKYE | Skye Bioscience, Inc. | 23.30M | - | 212,093 | - |
| 472 | VTGN | Vistagen Therapeutics, Inc. | 23.24M | - | 329,809 | 789.00K |
| 473 | OTLK | Outlook Therapeutics, Inc. | 22.91M | 4.29% | 1,469,209 | 205.70K |
| 474 | TPST | Tempest Therapeutics, Inc. | 22.81M | - | 71,337 | - |
| 475 | AEON | AEON Biopharma, Inc. | 22.49M | - | 97,989 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 22.01M | - | 94,234 | 3.55M |
| 477 | CRIS | Curis, Inc. | 21.98M | - | 422,967 | 9.44M |
| 478 | COCP | Cocrystal Pharma, Inc. | 20.81M | 48.04% | 137,317,487 | - |
| 479 | NNVC | NanoViricides, Inc. | 20.09M | - | 177,166 | - |
| 480 | VYNE | VYNE Therapeutics Inc. | 20.03M | - | 125,712 | 570.00K |
| 481 | PLRZ | Polyrizon Ltd. | 19.60M | - | 37,997 | - |
| 482 | JSPR | Jasper Therapeutics, Inc. | 19.26M | - | 891,070 | - |
| 483 | KTTA | Pasithea Therapeutics Corp. | 19.20M | - | 315,059 | - |
| 484 | CTXR | Citius Pharmaceuticals, Inc. | 19.11M | - | 287,088 | 3.94M |
| 485 | TVGN | Tevogen Bio Holdings Inc. | 18.57M | - | 17,959 | - |
| 486 | ALLR | Allarity Therapeutics, Inc. | 18.35M | - | 55,114 | 320.00K |
| 487 | LTRN | Lantern Pharma Inc. | 18.16M | - | 1,302,790 | - |
| 488 | CUE | Cue Biopharma, Inc. | 17.57M | - | 1,445,244 | 27.47M |
| 489 | ICU | SeaStar Medical Holding Corporation | 17.21M | - | 423,331 | 1.23M |
| 490 | GNTA | Genenta Science S.p.A. | 16.64M | - | 36,410 | - |
| 491 | LPCN | Lipocine Inc. | 14.96M | -77.84% | 7,402,225 | 1.98M |
| 492 | HIND | Vyome Holdings, Inc. | 14.95M | - | 5,546 | 319.71K |
| 493 | PHIO | Phio Pharmaceuticals Corp. | 14.87M | - | 100,933 | - |
| 494 | INTS | Intensity Therapeutics, Inc. | 14.48M | - | 23,905 | - |
| 495 | GTBP | GT Biopharma, Inc. | 14.18M | - | 407,711 | - |
| 496 | INAB | IN8bio, Inc. | 14.18M | - | 19,053 | - |
| 497 | BDRX | Biodexa Pharmaceuticals Plc | 14.15M | 400.00% | 24,245,485 | 104.90K |
| 498 | OSRH | OSR Holdings, Inc. | 14.11M | - | 903,925 | 2.91M |
| 499 | GNPX | Genprex, Inc. | 13.93M | -2.53% | 397,772 | - |
| 500 | JUNS | Jupiter Neurosciences, Inc. | 13.38M | - | 42,228 | 21.80K |